Zacks.com on MSN1d
Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion
Novartis NVS has entered into a global license and collaboration agreement with PTC Therapeutics PTCT for the latter’s ...
Positive Outlook on Olema Pharmaceuticals: Strategic Collaborations and Promising Trial Results Boost Buy Rating
J.P. Morgan analyst Anupam Rama has maintained their bullish stance on OLMA stock, giving a Buy rating on November 26.Don't Miss our Black ...
The Pharma Letter1d
Novartis deal and $250 million set Olema on the way
US biopharma Olema Pharmaceuticals has announced a clinical trial collaboration and supply agreement with Swiss pharma giant ...
Olema: Cash Infusion And Supply Agreement With Novartis Carries The Tide Forward
Olema Pharmaceuticals prepares for its OPERA-02 study, targeting ER+/HER2- breast cancer. Read why OLMA stock could benefit ...
Olema Oncology up 13% at $11.40 after entering supply pact with Novartis
EST Olema Oncology (OLMA) up 13% at $11.40 after entering supply pact with NovartisDon't Miss our Black Friday Offers:Unlock your ...
ETF Daily News18d
What is HC Wainwright’s Forecast for OLMA FY2024 Earnings?
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Equities research analysts at HC Wainwright decreased their FY2024 earnings per share estimates for shares of Olema Pharmaceuticals in ...
ETF Daily News11d
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Gap Up – Still a Buy?
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report)’s share price gapped up prior to trading on Friday .The stock had previously closed at $7.87, but opened at $8.21. Olema ...
Nasdaq4y
Olema Pharmaceuticals, Inc. Common Stock (OLMA)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...
Nasdaq4y
Olema Pharmaceuticals, Inc. Common Stock (OLMA)
*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces ...